Freda Lewis-Hall

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jitendra Wadhane, Attorney-in-Fact for Freda Lewis-Hall
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Freda Lewis-Hall

Form 4 holding Director

EXACT SCIENCES CORP

Security class
Common Stock
Shares / value
19,688
Estimated value
$1,447,068
Report date
08 Jun 2023
Price
$73.50
Ownership
Direct
Form 4 holding Director

Pyxis Oncology, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
45,867
Estimated value
$36,239
Report date
24 Mar 2026
Price
$0.9800
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CDT Equity Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
$29,820
Report date
05 Aug 2025
Price
$0.0710
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

1Life Healthcare Inc

Security class
Common Stock
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
$18.00
Ownership
Direct
Form 4 holding Director

1Life Healthcare Inc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

1Life Healthcare Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
22 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Freda Lewis-Hall

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .